BioCentury – FDA, NCI study will serve as prototype for streamlined pragmatic trials
Two U.S. government agencies, two pharmaceutical companies and an academic cooperative trials group are collaborating to conduct a pragmatic clinical trial of a combination therapy for advanced non-small cell lung cancer. They hope the trial, which FDA has dubbed Project Pragmatica, will be a model for quickly answering urgent questions that can shape clinical practice.…